Detalles de la búsqueda
1.
Correction: Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity.
Mol Cancer
; 22(1): 47, 2023 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927387
2.
Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity.
Mol Cancer
; 17(1): 50, 2018 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29455661
3.
Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/ß-Catenin signaling through Frizzled2-LRP6 assembly.
J Exp Clin Cancer Res
; 41(1): 133, 2022 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35395804
4.
A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-ß-catenin signaling-mediated drug resistance and adverse effects.
Theranostics
; 12(1): 105-125, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34987637
5.
Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70.
Theranostics
; 11(6): 2932-2952, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33456581
6.
Development of the phenylpyrazolo[3,4-d]pyrimidine-based, insulin-like growth factor receptor/Src/AXL-targeting small molecule kinase inhibitor.
Theranostics
; 11(4): 1918-1936, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33408789
7.
RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.
J Clin Invest
; 131(1)2021 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33393490
8.
Potent Anticancer Effect of the Natural Steroidal Saponin Gracillin Is Produced by Inhibiting Glycolysis and Oxidative Phosphorylation-Mediated Bioenergetics.
Cancers (Basel)
; 12(4)2020 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32276500
9.
The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression.
Cancer Res
; 80(11): 2257-2272, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32193288
10.
The natural compound gracillin exerts potent antitumor activity by targeting mitochondrial complex II.
Cell Death Dis
; 10(11): 810, 2019 10 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31649278
11.
Corrigendum to "Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells" [Cancer Lett. 412 (2018) 297-307].
Cancer Lett
; 568: 216289, 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423849
12.
Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells.
Cancer Lett
; 412: 297-307, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29061506
13.
Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer.
Sci Rep
; 8(1): 13924, 2018 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30224681
14.
RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.
J Clin Invest
; 133(10)2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37183821
15.
Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.
Clin Cancer Res
; 23(5): 1299-1311, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27582487
16.
Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.
Cancer Res
; 76(3): 686-99, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26645561
17.
Activation of insulin-like growth factor receptor signaling mediates resistance to histone deacetylase inhibitors.
Cancer Lett
; 361(2): 197-206, 2015 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25721083
18.
Corrigendum to "Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells" [Canc. Lett. 412 (2018) 297-307].
Cancer Lett
; 424: 136, 2018 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29573834
Resultados
1 -
18
de 18
1
Próxima >
>>